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Abstract. 
 
We have identified a human Bcl-2–interact-
ing protein, p28 Bap31. It is a 28-kD (p28) polytopic in-
tegral protein of the endoplasmic reticulum whose 
COOH-terminal cytosolic region contains overlapping 
predicted leucine zipper and weak death effector ho-
mology domains, flanked on either side by identical 
caspase recognition sites. In cotransfected 293T cells, p28 
is part of a complex that includes Bcl-2/Bcl-X
 
L
 
 and pro-
caspase-8 (pro-FLICE). Bax, a pro-apoptotic member 
of the Bcl-2 family, does not associate with the com-
plex; however, it prevents Bcl-2 from doing so. In the 
absence (but not presence) of elevated Bcl-2 levels, 
apoptotic signaling by adenovirus E1A oncoproteins 
promote cleavage of p28 at the two caspase recognition 
sites. Purified caspase-8 (FLICE/MACH/Mch5) and 
caspase-1(ICE), but not caspase-3 (CPP32/apopain/
Yama), efficiently catalyze this reaction in vitro. The 
resulting NH
 
2
 
-terminal p20 fragment induces apoptosis 
when expressed ectopically in otherwise normal cells. 
Taken together, the results suggest that p28 Bap31 is 
part of a complex in the endoplasmic reticulum that 
mechanically bridges an apoptosis-initiating caspase, like 
procaspase-8, with the anti-apoptotic regulator Bcl-2 or 
Bcl-X
 
L
 
. This raises the possibility that the p28 complex 
contributes to the regulation of procaspase-8 or a re-
lated caspase in response to E1A, dependent on the 
status of the Bcl-2 setpoint within the complex.
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D
 
espite 
 
the complexity of signals that can induce
apoptotic programmed cell death, many appear to
converge on a common execution pathway that is
initiated upon pro-enzyme activation of the Ced-3/ICE
(caspase) family of cysteine proteases (Kumar and Lavin,
1996; Alnemri et al., 1996). There are at least 10 known
members of the family whose activities lead to site-specific
cleavage and consequent activation/inactivation of various
target molecules. Additionally, these enzymes may oper-
ate as part of a cascade in which initiator caspases such as
caspase-8 (FLICE/MACH/Mch5) and caspase-10 (Mch4)
activate downstream effector caspases such as caspase-3
(CPP32/apopain/Yama; Fernandes-Alnemri et al., 1996;
Srinivasula et al., 1996; Muzio et al., 1997). Insight into the
likely mechanism of activation of initiator caspases has
come with the finding that the large pro-regions of initia-
tor caspases contain a death effector domain that physi-
cally links these pro-enzymes to an apoptotic signaling
complex. In the case of the Fas (CD95/Apo-1)/TNFR-1
complexes, recruitment of procaspase-8 involves the adap-
tor molecule FADD via interactions between the death ef-
fector domains within the two molecules (Boldin et al.,
1996; Muzio et al., 1996). Fas and TNFR-1, however, are
highly restricted in the death signals to which they re-
spond. An important question, therefore, is the extent to
which the Fas/TNFR-1 paradigm extends to other apop-
totic signaling pathways.
For many of these other death pathways, the decision to
induce apoptosis in response to specific death signals de-
pends on the status of various cellular regulators, including
p53 and the Bcl-2Bax family set point (White, 1996; Yang
and Korsmeyer, 1996). The latter arises through het-
erodimerization between the Bcl-2/Bcl-X
 
L
 
 (Hockenbery
et al., 1990; Strasser et al., 1991; Boise et al., 1993) and
Bax/Bak (Oltvai et al., 1993; Chittenden et al., 1995; Far-
row et al., 1995; Kiefer et al., 1995) family of suppressors
and promoters, respectively, in which the ratio of the het-
erodimerizing partners determines the outcome (cell death
or cell survival) in response to various death signals. Bad,
a more distantly related family member, is a regulator of
the set point (Yang et al., 1995) by a mechanism that is
governed by phosphorylation (Zha et al., 1996). This may
involve Bcl-2–dependent recruitment of Raf-1 kinase (Wang
et al., 1996
 
a
 
), albeit indirectly.
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Although it is now known that Bcl-2/Bcl-X
 
L
 
 controls the
apoptotic execution pathway at a point that is either at or
upstream of pro-enzyme activation of CPP32 (Armstrong
et al., 1996; Boulakia et al., 1996; Chinnaiyan et al., 1996),
how this is achieved remains to be elucidated. It is undoubt-
edly relevant, however, that Bcl-2/Bcl-X
 
L
 
 family members
are integral membrane proteins with a restricted subcellu-
lar distribution. They are anchored in the mitochondrial
outer membrane and ER/nuclear envelope via a single
COOH-terminal transmembrane segment, leaving a pro-
tease-sensitive domain exposed to the cytosol (Krajewski
et al., 1993; Nguyen et al., 1993; Gonzalez-Garcia et al.,
1994). Recent studies have revealed intriguing pore-form-
ing properties for the cytosolic domain of Bcl-X
 
L
 
 in syn-
thetic lipid bilayers (Minn et al., 1997), raising the possibil-
ity that the cytosolic domain may have the potential to
influence channel activities in these organelles. Mitochon-
dria and ER, either in parallel or in cooperation, are well
documented to control a number of electrochemical
events that may be linked to the induction of apoptosis
and to come under the control of Bcl-2 (Hockenbery et al.,
1993; Gottlieb et al., 1996; Lam et al., 1994). Moreover,
mitochondria may export pro-apoptotic molecules by a
Bcl-2–regulated mechanism (Kluck et al., 1997; Kroemer
et al., 1997; Yang et al., 1997); one of these, cytochrome c,
activates the caspase-3 zymogen when added to cytosolic
extracts. Whether or not mitochondria and ER contribute
to proximal events during the initiation of the caspase cas-
cade, however, remains to be elucidated. If so, Bcl-2/Bcl-X
 
L
 
may be strategically positioned within the cell to influence
both upstream and downstream events in this pathway, per-
haps involving coordinated signaling between the two or-
ganelles.
In addition to dimerizing members of the Bcl-2 family it-
self, several proteins have been suggested as candidate tar-
gets for Bcl-2 interaction (Fernandez-Sarabia and Bischoff,
1993; Boyd et al., 1994; Wang et al., 1994; Naumovski and
Cleary, 1996). With the exception of Raf-1 and its Bcl-
2–interacting effector, Bag-1 (Wang et al., 1996
 
a
 
,
 
b
 
), how-
ever, the majority of these have not been linked function-
ally to apoptosis. Here, we describe a polytopic integral
membrane protein of the ER, p28 Bap31, that is part of a
complex that contains Bcl-2 proteins and procaspase-8. In
the absence of Bcl-2, p28 itself becomes a target of a
FLICE/ICE-related caspase upon induction of apoptosis,
resulting in removal of a cytosolic segment that contains
overlapping death effector and leucine zipper homology
domains. The resulting product, p20, induces apoptosis
upon ectopic expression in transfected cells. It may be that
p28 is a Bcl-2–regulated component of an apoptosis signal-
ing pathway, possibly involving coordinated ER–mito-
chondrial events.
 
Materials and Methods
 
Cells and Viruses
 
Human KB cells expressing the neomycin resistance gene (
 
neo
 
) either
alone or together with 
 
BCL-2
 
 (Nguyen et al., 1994) were cultured in 
 
a
 
-MEM
supplemented with 10% FBS and 100 U/ml streptomycin and penicillin.
After reaching 80% confluency, the medium was replaced with fresh me-
dium containing either no virus or 25–35 PFU/cell adenovirus type 5 lack-
ing expression of E1B 19K (
 
pm
 
1716/2072; McLorie et al., 1991) or adeno-
virus type 5 expressing only the 243R form (12S) of E1A and no E1B
products (
 
dl
 
520E1B
 
2
 
; Shepherd et al., 1993). After incubation for 1 h at
37
 
8
 
C, fresh medium was added and cells were collected at various times
for analysis. Both forms of the virus elicit a cytotoxic response in infected
cells that exhibit all of the hallmark features of apoptosis (Nguyen et al.,
1994; Teodoro et al., 1995).
 
Bacterial Expression and Purification of 
 
32
 
P-labeled Bcl-2 Cytosolic Domain for 
Ligang Blot (Far Western) Analyses
 
cDNA encoding the cytosolic domain of human Bcl-2 (i.e., lacking the
COOH-terminal 21 amino acids) was inserted into the pTrchis vector (In-
vitrogen, Carlsbad, CA), and standard PCR methodology was used to
extend hexahistidine at the COOH terminus to include a heart muscle
kinase recognition sequence using the oligonucleotides 5
 
9
 
-CTAGCGC-
CCGCCGCGCCTCTGTGGAATTCTGAA and 5
 
9
 
-AGCTTTCAGA-
ATTCCACAGAGGCGCGGCGGGCG-3
 
9
 
. The final construct encoded
Bcl-2 (amino acids 1–218), hexahis, Arg, Arg, Ala, Ser-COOH, and the
protein designated Bcl-2
 
D
 
c21/his6/HMK. The Bcl-2 portion contained
three additional mutations that were introduced for reasons not related to
this project (Met 16 to Leu; Lys 17 to Arg; Lys 22 to Arg). Stable epithe-
lial cell lines that express full length Bcl-2 harboring these mutations were
found to be as effective as cells expressing wild-type Bcl-2 in countering
apoptotic death stimuli (not shown).
 
Escherichia coli
 
 MC1061 was transformed with p
 
Bcl-2
 
D
 
c21/his6/HMK
 
.
When 500-ml cultures reached an A
 
600
 
 of 0.6, they were treated with 1.0
mM IPTG, and cells were recovered by centrifugation 4 h later. Packed
cells (2.5–3.0 ml) were suspended in 15 ml extraction medium (20 mM Na
phosphate, pH 7.4, 0.5 M NaCl, 0.05% vol/vol Triton X-100, 10 mM 
 
b
 
-mer-
captoethanol, 1.0 mM PMSF, and 1.0 mM benzamidine) and were soni-
cated eight times with a Vibra Cell probe sonicator (Sonics & Materials,
Inc., Danbury, CT) operating at setting 7.5 for 15 s at 4
 
8
 
C. The sonicate
was adjusted to 10% (vol/vol) glycerol and centrifuged at 25,000 rpm for
30 min at 4
 
8
 
C in a Ti 50.2 rotor (Beckman Instruments, Inc., Fullerton,
CA). The supernatant was added to 1.2 ml Ni
 
2
 
1
 
-NTA agarose (QIAGEN
Inc., Chatsworth, CA; a 1:1 [vol/vol] mixture with extraction medium) and
incubated for 1.5 h at 4
 
8
 
C. The beads were washed extensively in extrac-
tion medium containing 20% (vol/vol) glycerol and 22 mM imidazole, and
Bcl-2
 
D
 
c21/his6/HMK was eluted in extraction medium containing 20%
glycerol and 0.3M imidazole. 1 liter of induced culture yielded 0.8–1.0 mg
protein that was 
 
.
 
95% pure. The purified protein was labeled with 
 
32
 
P af-
ter incubation with heart muscle kinase (HMK)
 
1
 
 and 
 
32
 
P[
 
g
 
-ATP], yielding
2.0–2.5 
 
3
 
 10
 
6
 
 cpm/
 
m
 
g protein, and it was used for ligand blotting as de-
scribed in Blanar and Rutter (1992).
 
Purification and Identification of p20 Fragment
 
KB cells were cultured in 20 15-cm plates until 80% confluency was
reached, and infected with 25 pfu/cell adenovirus type 5 lacking expres-
sion of E1B 19K (
 
pm
 
1716/2072). After 60 h, total cells (65–70% nonvia-
ble, as judged by exclusion of trypan blue) were collected and rinsed, and
the packed cells (
 
z
 
1.5 ml) were suspended in 6 ml ice-cold lysis medium
containing 10 mM Tris HCl, pH 7.5, 140 mM NaCl, 1.5 mM MgCl
 
2
 
, 0.5%
Triton X-100, and 1 mM PMSF) and separated into three equal portions.
Each was subjected to sonication for 4 X 10 s using an Artek probe sonica-
tor (Artek Systems Corp., Farmingdale, NY) operating at setting 6.0. The
combined sonicates were centrifuged at 11,000 
 
g
 
 for 20 min, and the super-
natant was mixed with 0.25 vol of 5
 
3
 
 SDS sample buffer (250 mM Tris
HCl, pH 6.8, 50% glycerol, 0.5% bromophenol blue, 10% SDS, and 1 M
DTT). The total volume was subjected to preparative 14% SDS-PAGE
using a Prep Cell 491 system (Bio Rad Laboratories, Hercules, CA) fitted
with a 37-mm diam resolving gel chamber. Fractions were collected at a
flow rate of 1 ml/min, assayed for the presence of p20 by ligand blotting
using 
 
32
 
P-Bcl-2
 
D
 
c21/his6/HMK as a probe, and the reactive peak fractions
combined and concentrated fivefold in a Centriprep-10 concentrator
(Amicon, Inc., Beverly, MA). The concentrated sample was mixed with
an equal volume of 0.12% trifluoroacetic acid and subjected to reverse-
phase HPLC in a system (1090; Hewlett-Packard Co., Palo Alto, CA) out-
fitted with a Vydac C4 column (The Nest Group, Inc., Southboro, MA)
(0.21 
 
3
 
 20 cm) prefixed with two SDS removal cartridges (2.1 
 
3
 
 20 mm).
 
1. 
 
Abbreviations used in this paper
 
: GST, glutathione S-transferase; HMK,
heart muscle kinase; TM, transmembrane. 
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The column was developed with a linear gradient of 0 to 80% 
 
n
 
-propyl al-
cohol containing 0.12% trifluoroacetic acid at a flow rate of 0.1 ml/min
and was monitored at A
 
280
 
. Fractions (0.1-ml) were collected, and those
containing Bcl-2–reactive p20, as judged by ligand blotting, were individu-
ally subjected to NH
 
2
 
-terminal peptide sequence analysis at Harvard Mi-
crochem (Harvard University, Cambridge, MA).
 
Cloning of p28 Bap31/CDM cDNA
 
The coding region of p28 was cloned by reverse transcription PCR using
human fibroblast RNA together with primers derived from the sequence
of human 
 
BAP31
 
 (these sequence data are available from GenBank/
EMBL/DDBJ under accession number X81817). Conditions were exactly
as described by Goping et al. (1995
 
a
 
), and we used 5
 
9
 
-TCTCTAGAA-
CAAACAGAAGTACTGGA-3
 
9
 
 as the antisense primer, and 5
 
9
 
-GAT-
CTAGACATCTTCCTGTGGGAA-3
 
9
 
 as the sense primer. Authenticity
was confirmed by DNA sequence analysis.
 
Glutathione S-Transferase Fusion Proteins
 
PCR was used to generate cDNA fragments corresponding to p28 amino
acids 1–246 (full length), 1–164, 122–164, and 165–246, using primers that
contained either 5
 
9
 
-BamH1 or 3
 
9
 
-EcoR1 overhangs, respectively. The
primers were 5
 
9
 
-GCGGATCCATGAGTCTGCAGTGGACT-3
 
9
 
 and 5
 
9
 
-
GCGAATTCTTACTCTTCCTTCTTGTC-3
 
9
 
 for p28 amino acids 1–246;
5
 
9
 
-GCGGATCCATGAGTCTGCAGTGGACT-3
 
9
 
 and 5
 
9
 
-GCGAATT-
CAGTCAACAGCAGCTCCCTT-3
 
9
 
 for p28 amino acids 1–164; 5
 
9
 
-GCGC-
GGATCCCTCATTTCGCAGCAGGCC-3
 
9
 
 and 5
 
9
 
-GCGAATTCAGT-
CAACAGCAGCTCCCTT-3
 
9
 
 for p28 amino acids 122–164; and 5
 
9
 
-GCG-
GATCCGGAGGCAAGTTGGATGTC-3
 
9
 
 and 5
 
9
 
-GCGAATTCTTAC-
TCTTCCTTCTTGTC-3
 
9
 
 for p28 amino acids 165–246. Fragments gener-
ated by PCR were digested with BamH1 and EcoR1, inserted between the
BamH1 and EcoR1 sites of pGEX-2t (Pharmacia Fine Chemicals, Piscat-
away, NJ), and the recombinant plasmids introduced into 
 
E. coli
 
 MC1061.
Packed cells from 500 ml of induced culture were recovered, suspended in
25 ml PBS and 0.1% Triton X-100, and sonicated using a Vibra Cell probe
sonicator operating at setting 7.5 for 4 
 
3
 
 15 s at 4
 
8
 
C. After centrifugation
at 25,000 rpm in a Beckman Ti 50.2 rotor for 25 min, the supernatant was
recovered, mixed with 750 
 
m
 
l of a 1:1 suspension of glutathione-Sepharose
4B beads, and the mixture rotated at 4
 
8
 
C for 45 min. After extensive wash-
ing of the beads in PBS and 0.1% Triton X-100, glutathione S-transferase
(GST) fusion protein was eluted with 3 ml of 50 mM Tris HCl, pH 8.0, and
12 mM reduced glutathione.
 
Antibodies
 
GST fusion proteins were injected into chickens, and the resulting IgY an-
tibodies were recovered from the eggs, exactly as described by Goping et
al. (1995
 
a
 
). After adsorption of IgY that reacted with immobilized GST,
antibodies specific for p28 sequences were purified by affinity binding to
immobilized GST-p28(165-246) or GST-p28(122-164) fusion protein, us-
ing the methods described in the Amino Link Plus kit (Pierce Chemical
Co., Rockford, IL).
 
Transient Transfections
 
CHO LR73 cells were seeded at a density of 5 
 
3
 
 10
 
5
 
 cells/well in six-well
plates. 24 h later, the cells in each well were transfected by calcium phosphate
precipitation with 0.5 
 
m
 
g luciferase reporter plasmid, 10 
 
m
 
g RcRSV-p28 or
RcRSV-p20, and 10 
 
m
 
g sheared salmon sperm DNA (Goping et al.,
1995
 
b
 
). After 24 h, cells were shocked with 15% glycerol and collected 24 h
later. Cells from each well were lysed in 0.4 ml 0.5% NP-40 and 50 mM
Tris HCl, pH 7.8, and aliquots were assayed for luciferase activity as de-
scribed previously (Goping et al., 1995
 
b
 
). 293T cells in 10-cm culture
plates were similarly transfected with 15 
 
m
 
g total plasmid DNA when cells
reached 50–60% confluency.
 
Coimmunoprecipitations
 
Approximately 30 h after transfection, 293T cells were washed in PBS and
homogenized in 1.0 ml lysis medium/10-cm culture plate (50 mM Hepes,
pH 7.4, 150 mM NaCl, 1 mM ethylenediamine tetraacetate, 0.5% vol/vol
NP-40, 10 
 
m
 
g/ml aprotinin, 10 
 
m
 
g/ml leupeptin, and 1 mM PMSF). After
centrifugation at 11,000 
 
g
 
, the supernatant was incubated with 50 
 
m
 
l of a 1:1
slurry of protein G Sepharose for 1 h at 4
 
8
 
C. The Sepharose was removed
and the supernatant incubated with mouse M2 anti-Flag antibody (IBI-A
Kodak Co., New Haven, CT) at 4
 
8
 
C for 6 to 8 h, at which time 20 
 
m
 
l of a 1:1
slurry of protein G Sepharose was added. After 1 h at 4
 
8
 
C, the beads were
recovered, washed, and boiled in SDS sample buffer. After SDS-PAGE
and transfer to nitrocellulose, blots were developed with either mouse
anti-Myc 9E1D antibody or mouse anti-HA 12CA5 antibody (both from
Babco, Berkeley, CA) or rabbit anti-Bax sc-526 antibody (Santa Cruz
Biotechnology, Santa Cruz, CA).
 
Results
 
Appearance and Identification of a Bcl-2–interacting 
Polypeptide after Induction of Apoptosis by E1A
 
To detect potential Bcl-2–interacting polypeptides by
ligand blot (Far Western) analysis, a 
 
32
 
P-labeled probe was
constructed by expressing a modified version of the cyto-
solic domain of Bcl-2 in 
 
E. coli.
 
 To that end, the last 21 amino
acids of Bcl-2 were deleted and substituted with hexahisti-
dine (his6) plus an HMK recognition peptide to facilitate
purification and 
 
32
 
P labeling, respectively. Isolation condi-
tions were developed in which the recombinant protein
was purified as a soluble product comprised of mixed
monomers and dimers at pH 7.4, as judged by FPLC mo-
lecular sieve chromatography. The 
 
32
 
P-labeled probe (
 
32
 
P-
Bcl-2
 
D
 
c21/his6/HMK) readily detected either recombi-
nant Bcl-2 or Bax as the only radioactive products on a
ligand blot of total bacterial lysate (not shown). When
used as a probe to analyze potential Bcl-2–interacting
polypeptides in cells induced to undergo apoptosis in re-
sponse to various stimuli (including adenovirus E1A ex-
pression or treatment with puromycin), a product of 
 
z
 
20
kD in size (p20) as judged by SDS-PAGE was observed
consistently.
Fig. 1 shows one such example after infection of 
 
neo
 
-
and 
 
BCL-2
 
–expressing human KB cells with adenovirus
type 5 producing either 12S E1A mRNA (which encodes
243R E1A protein) or both 12S and 13S E1A mRNAs
(which encode 243R and 289R E1A proteins, respec-
tively), but lacking expression of the dominant suppressor
of apoptotic cell death, E1B 19-kD protein (19K). Induc-
tion of apoptotic cell death by either virus (Nguyen et al.,
1994; Teodoro et al., 1995) was accompanied by the ap-
pearance of p20 Bcl-2–binding activity, whereas apparent
binding to Bax did not change significantly during the time
course of infection. Of note, however, is the observation
that stable expression of Bcl-2 in these cells countered cell
death and prevented the appearance of p20 Bcl-2–binding
activity after viral infection.
Identification of the p20 Bcl-2–binding polypeptide was
obtained by NH
 
2
 
-terminal peptide sequence analysis of
p20 after its purification by a combination of differential
solubilization in detergent, preparative SDS-PAGE, and
reverse-phase HPLC (Fig. 2, 
 
A
 
 and 
 
B
 
). Several individual
HPLC fractions were subjected to peptide sequence analy-
sis to detect a polypeptide sequence whose appearance
correlated with the appearance of p20 Bcl-2–binding activ-
ity (Fig. 2). One candidate sequence emerged, and it was
the only sequence that was detected in the peak fraction of
Bcl-2–binding activity (Fig. 2 
 
B
 
, fraction 54). It showed a
perfect match with amino acids 2–11 of human Bap31 (these
sequence data available from GenBank/EMBL/DDBJ un-
der accession number X81817)/CDM (these sequence data
available from GenBank/EMBL/DDBJ under accession 
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number Z31696), suggesting that p20 derives from the
NH
 
2
 
 terminus of this 27,991-kD (p28) protein. Reverse
transcription-PCR analysis of the p28 coding region, using
total RNA obtained from KB cells after induction of apop-
tosis, showed no evidence that p20 arose by differential
splicing of p28 mRNA (data not shown). As demonstrated
below, Bcl-2 also associates with full length p28 in vitro
and in vivo; failure to observe this interaction in the origi-
nal ligand blot analyses (Fig. 1) was likely the result of rel-
atively inefficient transfer of p28 to nitrocellulose blots.
p28 is identical to a protein previously described as
Bap31 and CDM, which is ubiquitously expressed (Adachi
et al., 1996). CDM was discovered because of its proximity
to the adrenoleukodystrophy locus (Mosser et al., 1994),
and Bap31 because it was one of several polypeptides that
were found in immunoprecipitates of the B cell receptor
complex obtained from detergent-solubilized cells (Kim et
al., 1994; Adachi et al., 1996). Another protein present in
these precipitates, Bap32, is a homologue of the rat pro-
tein prohibitin (McClung et al., 1989). It is noteworthy,
however, that prohibitin has recently been localized to the
mitochondrial periphery in transfected BHK cells (Ikonen
et al., 1995) and that Bap31 (p28) is largely restricted to
the ER in rat liver hepatocytes (see below), whereas the B
cell receptor is located in the plasma membrane.
 
p28 Bap31
 
Fig. 2 
 
C highlights several predicted motifs in the human
p28 sequence. There are three potential transmembrane
(TM) segments (Kyte and Doolittle, 1982) located in the
NH2-terminal half of the molecule. TM1 and TM3 each con-
tain charged residues. Additionally, two potential caspase
cleavage sites comprised of identical P1–P4 tetrapeptide
recognition sequences (Ala-Ala-Val-Asp) plus a preferred
small amino acid (Gly) in the P19 position are located at
positions 164 and 238 in the polypeptide, on either side of
a predicted leucine zipper domain (Fig. 2 C) and overlap-
ping weak homology to death effector domains found in
such proteins as procaspase-8/10 and FADD (Fig. 2 D).
Cleavage at the proximal caspase recognition site would
generate a product (calculated Mr of 18.8 kD) similar in
size to p20. Interestingly, the distal caspase recognition
site is lacking in the mouse sequence (Fig. 2 D). Finally,
Figure 1. Appearance of a
Bcl-2–interacting polypep-
tide during E1A-induced apop-
tosis. KB cells expressing
neomycin resistance, either
alone (Neo) or together with
Bcl-2, were infected with ei-
ther adenovirus dl520E1B2
(expressing 12S E1A and no
E1B products) or pm1760/
2072 (expressing 12S and 13S
E1A but not E1B 19K). At
the indicated times after in-
fection, samples of cells were
either assessed for viability
by exclusion of trypan blue
(graph) or prepared for
ligand blot (Far Western)
analysis, as described in Ma-
terials and Methods, using
32P-Bcl-2Dc21/his6/HMK as a
probe (upper panel, Bcl-
2–expressing cells; lower
panel, Neo control cells).
Ligand blots were visualized
by phosphorimaging. The ra-
dioactive band associated
with a polypeptide of Mr 20
kD is labeled p20, whereas
that which comigrates with
Bax is designated p21 Bax.
The latter was determined
using a blot cut along the ver-
tical midline of a protein lane
and developing one half by
immunoblot analysis with
anti–human Bax (Chen et al.,
1996) and the other by ligand
blotting with 32P-Bcl-2Dc21/
his6/HMK (results not shown).Ng et al. Bcl-2 and pro FLICE-associated Bap31 331
Figure 2. Identification of p20. (A) Preparative SDS-PAGE of differentially solubilized protein from KB cells 60 h after infection with
adenovirus pm1760/2072. Aliquots of fractions eluted from the gel were assayed by 32P-Bcl-2Dc21/his6/HMK Far Western, and the ra-
dioactive bands corresponding to p20 and p21 Bax were detected and quantified by phosphorimaging. The levels relative to the maximal
signal detected (set at 100) were plotted as a bar graph (upper panel). Equal aliquots from the same fractions were also subjected to an-
alytical 12% SDS-PAGE, and the gels were stained with Coomassie brilliant blue (lower panel). The positions of molecular mass marker
proteins are indicated. black, p20; gray, Bax. (B) Proteins eluting from preparative SDS-PAGE between 190 and 220 ml were concen-
trated and resolved by reverse-phase HPLC. The upper panel shows the A280 profile. Equal aliquots from all fractions were assayed for
32P-Bcl-2Dc21/his6/HMK–interacting protein by Far Western, for which only p20 was detected. Amounts relative to the maximal signal
detected (set at 100) were plotted as a bar graph (lower panel). Fractions 52, 53, 54 (peak activity), and 55 were individually subjected to
NH2-terminal peptide sequence analysis. (C) Polypeptide sequence of p28 Bap31/CDM (single-letter code). Peptide sequencing of p20
revealed a perfect match with amino acids 2–11 of human Bap31(underlined; these sequence data available from GenBank/EMBL/
DDBJ under accession number X81817). This was the only detectable sequence in fraction 54, was detectable together with other se-
quences in fraction 53, and was not detected in fractions 52 and 55. Predicted TM segments are boxed and contain charged amino acids
in TM1 and TM3 (asterisks). The predicted caspase recognition sites, AAVD?G, are highlighted, and cleavage is denoted by arrows fol-
lowing Asp at positions 164 and 238. A potential leucine zipper located between the caspase recognition sites is denoted by bold letters,
as is the KKXX ER retention signal at the COOH terminus. (D) Comparison of putative death effector domain sequences for the indi-
cated proteins. The sequences, given in the single-letter amino acid code, were obtained from GenBank/EMBL/DDBJ, and their rela-
tive positions in the molecule are shown in parentheses. Sequences were aligned using the PILEUP program of the GCG software pack-
age and were optimized by spacing (shown as dashes). Identical residues and conserved substitutions that were recorded for at least half
of the sequences analyzed are shaded in gray.The Journal of Cell Biology, Volume 139, 1997 332
the molecule terminates in Lys-Lys-Glu-Glu, which con-
forms to a canonical KKXX COOH-terminal signal that
retains integral ER proteins containing COOH termini ex-
posed to the cytosol within this organelle, preventing their
exit into the distal secretory pathway (Jackson et al., 1993).
As shown in Fig. 3, p28 was efficiently inserted cotrans-
lationally into dog pancreas microsomes. In contrast to b-lac-
tamase, which was translocated across the ER membrane
and deposited in the lumen as a soluble protein, p28 was
recovered as an integral protein after release from the ri-
bosome. Whereas the processed form of b-lactamase was
protected from external protease (Fig. 3, lane 4) and liber-
ated from microsomes by alkaline extraction (Fig. 3, lane
3), p28 was resistant to alkaline extraction (Fig. 3, lane 7),
and exhibited sensitivity to external protease (Fig. 3, lane
8), resulting in the generation of proteolytic fragments that
would be expected for a multispanning integral protein
with an exposed cytosolic domain. Unlike b-lactamase,
whose NH2-terminal signal sequence was removed during
translocation (Fig. 3, compare lanes 1 and 4), processing of
p28 was not observed (Fig. 3, compare lanes 5 and 6), sug-
gesting that insertion into the microsomal membrane is
initiated by an uncleaved signal anchor. Though not stud-
ied in detail, the observed properties of p28 (Fig. 3), to-
gether with predictions for the orientation of transmem-
brane segments in the ER based on charge difference rules
(von Heijne, 1986; Hartmann et al., 1989), suggest a topol-
ogy for p28 in the ER membrane in which the NH2 terminus
of this triple-spanning polypeptide faces the lumen, leaving
an z13-kD COOH-terminal fragment containing predicted
caspase cleavage sites, leucine zipper/death effector-like
domain, and ER retention motif exposed to the cytosol (see
Fig. 3). Biochemical fractionation and cryoimmunocyto-
chemical electron microscopy confirmed that p28 is predom-
inantly located in the ER in rat hepatocytes (not shown).
Recombinant p28 and p20 Interact with Bcl-2
Various p28 fusion proteins were constructed in which
GST was linked to p28 amino acids 1–246 (full length p28),
1–164 (p20), 122–164, and 165–246. These constructs, to-
gether with GST itself, were purified, and equal amounts
were examined for their ability to bind to the cytosolic do-
main of Bcl-2 in a ligand blot assay. As shown in Fig. 4 A,
reactivity was observed for both GST-p28 (lane 5) and
GST-p20 (lane 4), with weak activity possibly registering
with the COOH-terminal 165–246 amino acid domain
(lane  2), and none detected for the middle 122–164 amino
acid domain (lane 3) or for GST alone (lane 1).
Bcl-2 Proteins and Procaspase-8 (pro-FLICE)
Associate with p28 In Vivo
Epitope-tagged versions of Bcl-XL, Bcl-2, and wild-type
procaspase-8 were expressed separately or in combination
in 293T cells, together with either p28-Flag or control Flag.
The presence of p28-associated proteins present in immu-
noprecipitates recovered with anti-Flag was then assessed
by immunoblot (Western) analysis (Fig. 4 B). To avoid in-
terference with the function of the ER retention signal in
p28, the Flag epitope was inserted just upstream of the
KKEE motif at the COOH terminus of the protein. As
judged by coimmunoprecipitation, Bcl-XL, procaspase-8,
and Bcl-2 each demonstrated a specific association with
p28 (Fig. 4 B, lanes 3, 8, and 14, respectively). Procaspase-8
was observed as a doublet band that migrated immediately
below the Ig heavy chain; transcription–translation of the
cDNA in vitro likewise generated a doublet of similar size
(not shown). Interestingly, Bcl-XL and procaspase-8, when
expressed in combination, did not mutually antagonize
each other’s ability to associate with p28 (Fig. 4 B, lanes 5
and 10; note the lower input levels of Bcl-XL in the cell ly-
sate in lane 5). Although some activation of wild-type pro-
caspase-8 might be expected, the full length proenzyme
Figure 3. Insertion of p28 into ER microsomes. Pre–b-lactamase
(lanes 1–4) and p28 (lanes 5–8) mRNA was translated in a rabbit
reticulocyte lysate system in the presence of [35S]methionine, in
the presence (lanes 2–4 and 6–8) or absence (lanes 1 and 5) of ri-
bosome-stripped canine pancreas microsomes (Walter and Blo-
bel, 1983). At the end of the reaction, microsomes were recov-
ered and analyzed by SDS-PAGE and fluorography either
directly (lanes 2 and 6) or after isolation of alkali-insoluble
(NaCO3, pH 11.5) product (lanes 3 and 7; Nguyen et al., 1993), or
after treatment with proteinase K (lanes 4 and 8; McBride et al.,
1992). The positions of p28, pre–b-lactamase (pre-b-L), and pro-
cessed b-lactamase (b-L) are indicated, as is the gel front. c,
marker translation product. The schematic shown below the fluo-
rogram depicts the deduced topology of p28 in the ER membrane
(see text).Ng et al. Bcl-2 and pro FLICE-associated Bap31 333
Figure 4. Associations of p28 with Bcl-2,
Bcl-XL, and procaspase-8 (pro-FLICE).
(A) GST (lane 1) or GST fused to p28
amino acids 165–246 (lane 2), 122–164
(lane  3), 1–164 (lane 4), and 1–246 (lane 5)
were expressed in bacteria, purified, and
transferred to nitrocellulose in duplicate
after SDS-PAGE. One blot was stained
with Ponceau S and the other probed by
ligand blotting (Far Western) with 32P-
Bcl-2Dc22/his6/HMK, as indicated. Con-
structs and results are summarized below
the blots. (B) Standard recombinant DNA
manipulations were used to create cDNAs
encoding Bcl-XL tagged at the COOH ter-
minus with the Myc epitope EQKLI-
SEEDL (Chinnayan et al., 1997); pro-
FLICE tagged at the COOH terminus
with the hemagglutinin (HA) epitope,
YPYDVPDYA (Chinnayan et al., 1997);
Bcl-2 tagged at the NH2 terminus with the
HA epitope (Nguyen et al., 1994); and p28
tagged with the Flag epitope, in which the
Flag sequence MDYKDDDDKA was in-
serted between Pro240 and Met241 of p28.
The recombinant cDNAs, or Flag DNA
alone (Control-Flag), were inserted into
pcDNA 3 (Invitrogen) or RcRSV (Phar-
macia Fine Chemicals) (HA-Bcl-2) and
transfected into 293T cells, as indicated
(pluses and minuses). After incubation of
cell lysates with anti-Flag antibody, immu-
noprecipitates (ip) and lysates were re-
solved by SDS-PAGE, transferred to ni-
trocellulose, and the blot developed with
the indicated antibody and visualized by
enhanced chemiluminescence. Ig HC, im-
munoglobulin heavy chain. (C) Same as in
B, except that Bax was included in cotrans-
fections, as indicated.The Journal of Cell Biology, Volume 139, 1997 334
was readily detectable at similar levels in both the pres-
ence and absence of Bcl-XL (Fig. 4 B, lanes 8 and 10).
Finally, the pro-apoptotic member of the Bcl-2 family,
Bax (Oltvai et al., 1993), did not coimmunoprecipitate
with p28 after their coexpression in 293T cells (Fig. 4 C,
lane 5), despite the fact that significant expression levels of
transfected Bax were recorded (lanes 2 and 3). However,
Bax prevented Bcl-2 from associating with p28 (Fig. 4 B,
compare lanes 11 and 12). Although the level of Bcl-2 in
cell lysates was somewhat lower in transfectants contain-
ing Bax (Fig. 4 B, compare lanes 8 and 9), such a level of
Bcl-2 would otherwise have been sufficient to readily de-
tect coimmunoprecipitation of Bcl-2 and p28.
p28 is Cleaved to p20 by FLICE-related Caspase
To test the possibility that the predicted caspase recogni-
tion sequences in p28, AAVD?G, can in fact be recognized
by one or more of these enzymes, 35S-labeled p28 trans–
cription–translation product was incubated with increasing
concentrations of either caspase-1 (ICE) or caspase-3
(CPP32) in vitro (Nicholson et al., 1995), and the products
were examined after SDS-PAGE (Fig. 5 A). Little reactivity
was observed for caspase-3 over a wide range of enzyme
concentration. caspase-1, on the other hand, generated
two products (denoted a and b in Fig. 5 A), whose appar-
ent sizes in SDS gels (z27 and z20 kD, respectively) are
consistent with cleavage occurring at both AAVD/G sites.
Of note, p28 was more sensitive to cleavage by caspase-8
(FLICE) than by caspase-1 (ICE; Fig. 5 B).
Two cleavage products of p28, similar in size to those
seen in vitro, were also observed in cells that had been in-
duced to undergo apoptotic cell death in response to infec-
tion by 19K-defective adenovirus (Fig. 6). In Fig. 6 A, p28
cleavage during apoptosis in vivo was analyzed using anti-
bodies raised in chicken to either of two regions of the
protein: p28 amino acids 122–164 (a p28-M) and 165–246
(a p28-C). Cleavage products were detected with a p28-M
but not with a p28-C, a finding consistent with the sugges-
tion from peptide sequence analysis that the p20 cleavage
product derives from the NH2 terminus of p28 (Fig. 2). a
p28-C also failed to detect the larger of the two cleavage
products (designated a in Fig. 6 A) despite the predicted
overlap of this product with the sequence injected into chick-
ens. Presumably, this means that the extreme eight amino
acids of p28 are critically important for epitope recognition
by this antibody. Finally, protein electrophoretic blots were
developed from apoptotic cell extracts, cut in half along
the vertical midline of a protein lane, and one half probed
with a p28-M and the other with 32P-Bcl-2Dc21/his6/HMK.
p20 detected by the Bcl-2 probe migrated exactly with p20
detected by a p28-M immunoblotting (not shown).
In Fig. 6 B, the effect of Bcl-2 on the appearance of p28
cleavage products after cell infection with 19K-deficient
and  b in the schematic at the bottom of the figure. (B) Same anal-
ysis as in A, except that p28 was incubated with purified ICE or
FLICE, and the resulting p20 cleavage product was quantified us-
ing a Phosphorimager. 1 U of caspase enzyme activity is equiva-
lent to 1 pmol aminomethylcoumarin liberated from fluorogenic
tetrapeptide-AMC per min at 258C at saturating substrate con-
centrations (Nicholson et al., 1995).
Figure 5. In vitro cleavage of p28 by caspase-1 (ICE) and
caspase-8 (FLICE) but not by caspase-3 (CPP23). (A) 35S-labeled
transcription–translation product of p28 cDNA was incubated
with increasing concentrations of CPP32 or ICE, and the prod-
ucts were resolved by SDS-PAGE (Nicholson et al., 1995). Units
of enzyme added per 25 ml reaction mixture were: none (lane 1),
0.0056 (lane 2), 0.98 (lane 3), 1.95 (lane 4), 3.9 (lane 5), 7.8 (lane
6), 15.6 (lane 7), 31.2 (lane 8), 62.5 (lane 9), and 125 (lane 10).
The positions of polypeptide molecular mass markers are shown.
The arrows designated a and b denote cleavage products whose
sizes are consistent with cleavage of p28 at the sites indicated by aNg et al. Bcl-2 and pro FLICE-associated Bap31 335
adenovirus was examined using the a p28-M antibody. In
the absence of Bcl-2 expression, the time course of appear-
ance of these products closely followed the time course for
activation of procaspase-3 (CPP32), as judged by process-
ing of the pro-enzyme to the p17 catalytic subunit (Fig. 6
B, lanes 6–10). However, both p28 cleavage and pro-
caspase-3 processing were blocked in virus-infected cells
that express Bcl-2 (Fig. 6 B, lanes 1–5).
Ectopic Expression of p20 Induces Apoptosis
CHO (neo) cells were transiently cotransfected with a lu-
ciferase reporter gene together with RcRSV expressing either
p28 or p20. Subsequent measurements revealed that coex-
pression of p20 with the reporter severely depressed the
amount of luciferase activity obtained relative to coexpres-
sion with p28 (Fig. 7 A). p28, on the other hand, had no
deleterious effect on the recovery of luciferase activity com-
pared to a control RcRSV plasmid that did not encode pro-
tein (not shown). If these same transfections were con-
ducted in cells stably expressing Bcl-2, however, Bcl-2 largely
Figure 6. Induction of p28 cleavage and procaspase-3 (pro-
CPP32) processing during apoptosis in vivo. (A) Cell extracts
were obtained from KB cells that had either been infected for 60 h
with adenovirus pm1716/2072 lacking expression of E1B 19K or
had been mock infected (1 or 2 Apoptosis, respectively). After
12% SDS-PAGE and transfer to nitrocellulose, blots were incu-
bated with affinity-purified chicken antibody against p28 amino
acids 165–246 (a p28-C) or p28 amino acids 122–164 (a p28-M)
and were developed with secondary antibody conjugated either
to HRP and visualized by electrochemiluminescence (Amersham
Intl., Arlington Heights, IL) (a p28-M) or to alkaline phos-
phatase and visualized with NBT/BCIP (Boehringer Mannheim
Biochemicals, Indianapolis, IN) (a p28-C), according to the man-
ufacturer’s instructions. Bands corresponding to p28 are indi-
cated. Arrows labeled a and b denote products whose sizes are
consistent with cleavage of p28 at the sites designated a and b in
the schematic. (B) KB cells expressing neomycin resistance either
alone (minus Bcl-2, lanes 6–10) or together with Bcl-2 (plus Bcl-2,
lanes  1–5) were infected with adenovirus pm1716/2072 lacking
expression of E1B 19K and cell extracts prepared at 0, 24, 36, 48,
and 60 h postinfection (p.i.; lanes 1 and 6, 2 and 7, 3 and 8, 4 and
9, and 5 and 10, respectively). Aliquots (15 mg protein) were sub-
jected to 12% SDS-PAGE, transferred to nitrocellulose, and
blots were probed with antibody against p28-M or against the 17-
kD subunit of CPP32 (Boulakia et al., 1996), and the products
were developed as described in A. The positions of p28 and the
cleavage products a and b are indicated in the upper panels. The
arrow denotes a cross-reacting product whose appearance is vari-
able (e.g., it did not appear in A). The positions of full length pro-
CPP32 and the processed 17-kD subunit (p17) and putative
29-kD processing intermediate (asterisk) are indicated in the lower
panels.
Figure 7. Ectopic expression of p20 induces apoptosis. (A) CHO
LR73 cells expressing neomycin resistance, either alone (2 Bcl-2)
or together with Bcl-2 (1 Bcl-2), were cotransfected with a lu-
ciferase reporter plasmid and Rc/RSV expressing either full
length p28 or p28 amino acids 1–164 (i.e., p20). After 2 d, cells
were recovered, analyzed for luciferase activity, and the enzyme
activity expressed relative to the values obtained in the presence
of p28 (arbitrarily set at 100). The results shown are the average
of two separate experiments. (B) CHO cells were transfected
with the p28 and p20 expression plasmids together with pHook
(Invitrogen). 24 h later, transfected cells were recovered with
Capture-Tec beads, cultured on coverslips, stained with 49,69-dia-
midino-2-phenyl indole (DAPI), and visualized under a micro-
scope.The Journal of Cell Biology, Volume 139, 1997 336
overcame the dominant negative influence of p20 on luciferase
activity (Fig. 7 A), presumably because p20 could no longer
interfere with normal p28 function. Because of this protec-
tive effect by Bcl-2, we conclude that the negative influence
of p20 on luciferase activity was the result of induction of apop-
tosis. This was confirmed by microscopic analysis, which
revealed apoptotic nuclei in p20- but not p28-transfected
cells (Fig. 7 B). The findings described in Fig. 7 have been
consistently observed many times and in different cell types.
Discussion
We have identified p28 Bap31 as a component of a puta-
tive apoptotic signaling complex in the ER that also in-
cludes Bcl-2/Bcl-XL and procaspase-8 (pro-FLICE). At
least with respect to recruitment of procaspase-8, the func-
tion of the p28 complex may be analogous to Fas and
TNFR-1, apoptotic receptors in the plasma membrane
that respond to FasL and TNF, respectively, by activating
receptor-associated procaspase-8 and initiating the caspase
cascade (for review see Nagata, 1997). Association of pro-
caspase-8 with these receptor complexes is achieved through
interactions of its death effector domain with an analogous
domain in the adaptor molecule FADD (Boldin et al.,
1996; Muzio et al., 1996). Despite the fact that p28 con-
tains a weak death effector homologous domain within its
cytosolic region, however, we find no evidence that p28
and procaspase-8 interact directly, at least based on bind-
ing assays in vitro (not shown). Thus, evidence for an au-
tonomously functional death effector domain in p28 is
lacking. The observed association of procaspase-8 with
p28 in vivo, therefore, likely depends on an as yet uniden-
tified adaptor component within the p28 complex. Expres-
sion of the adenovirus E1A oncoprotein presumably re-
sults in activation of procaspase-8, as judged by the
ensuing rapid and specific cleavage of p28 in vivo at sites
that exhibit a marked substrate preference by purified
caspase-8 in vitro. Such a claim is consistent with the find-
ing that CrmA, an inhibitor of FLICE-related caspases but
not of caspase-3 (Srinivasula et al., 1996; Zhou et al., 1997),
significantly retards the onset of E1A-induced apoptosis in
viral infected cells (our unpublished data). It remains to be
determined, however, if E1A results in activation of the
procaspase-8 (or related caspase) members that are di-
rectly associated with the p28 complex. Whichever the
case, p28 is cleaved to p20 after E1A expression, and the
p20 molecule itself can induce cellular apoptotis. p20 may
act either to ampilify a caspase-8–initiated protease cas-
cade (Srinivasula et al., 1996; Muzio et al., 1997) or to con-
tribute to a parallel pathway. Significantly, Bcl-2 blocks
the appearance of p20 after E1A expression. It remains to
be determined whether this is because Bcl-2 subverts the
E1A signal that results in activation of procaspase-8 or be-
cause it protects p28 against activated caspase-8. Bax, a
pro-apoptotic member of the Bcl-2 family, does not ap-
pear to associate with the p28 complex. However, it blocks
Bcl-2 from doing so, presumably because competing inter-
actions between Bcl-2 and Bax (Oltvai et al., 1993) pre-
vent interactions between Bcl-2 and p28.
There is a growing body of evidence that mitochondria
may play an important role in apoptotic signaling leading
to downstream activation of caspase-3 and other effector
proteases (Kroemer et al., 1997; Kluck et al., 1997; Yang et
al., 1997). Moreover, these or other mitochondrial events
may be controlled by phosphorylation (Wang et al., 1996a;
Zha et al., 1996) which in turn may be influenced by Bcl-2
(Wang et al., 1996a). Under normal conditions, Bcl-2 and
Bcl-XL are localized to both the mitochondrial outer mem-
brane and ER, suggesting that events influencing these
proteins may apply to both membrane sites. Nevertheless,
replacing the COOH-terminal Bcl-2 signal anchor with ei-
ther a heterologous mitochondrial outer membrane signal
anchor (Mas70p; McBride et al., 1992) or a posttransla-
tional ER-specific insertion sequence (aldehyde dehydro-
genase; Masaki et al., 1994) can restore anti-apoptotic ac-
tivity to the protein (Nguyen et al., 1994; our unpublished
data). Similar results have been obtained with other mito-
chondrial- and ER-specific targeting sequences (Zhu et
al., 1996). These findings are consistent with the idea that
ER and mitochondria may cooperate to elicit apoptotic
signals, and that regulation of these signals by Bcl-2 at ei-
ther compartment may be effective under certain condi-
tions. Alternatively, apoptotic regulatory systems at the
two membrane sites may respond differentially to individ-
ual inducers. Although the potential role for Ca21 in apop-
tosis remains unresolved, the ability of mitochondria to
decode ER-transmitted oscillating Ca21 signals (Hojnóc-
zky et al., 1995; Camacho and Lechleiter, 1995; Jouaville et
al., 1995) is one example in which the two organelles
clearly cooperate to regulate metabolic events. Consistent
with a role for calcium signaling in apoptosis is the recent
finding that inhibition of the type I inositol 1,4,5-triphos-
phate receptor calcium release channel in the ER confers
resistance to diverse apoptotic stimuli. It remains to be de-
termined whether or not p28 is involved in either this or
another ER–mitochondrial program. If so, however, the
fact that predicted transmembrane segments 1 and 3 con-
tain positively charged residues implies that p28 may be
part of a larger complex that thermodynamically stabilizes
these residues within the membrane lipid bilayer. Such a
structure might also be compatible with the predicted
pore-forming properties of the Bcl-XL (Minn et al., 1997)
and Bcl-2 (Schendel et al., 1997) cytosolic domains and
contribute to p28–Bcl-2 interactions.
Finally, genetic studies in Caenorhabditis elegans have
identified and ordered a core machinery for regulation of
cell death in which the Bcl-2 homologue, Ced-9, prevents
Ced-4 from activating the ICE-like caspase Ced-3 (Hen-
gartner et al., 1996; Shaham and Horvitz, 1996). Reconsti-
tution of these events in mammalian cells has recently
been achieved (Chinnaiyan et al., 1997; Wu et al., 1997)
and has revealed that Ced-4 can mechanically link the ini-
tiator procaspase-8 and -1 pro-enzymes with Bcl-XL
(Chinnaiyan et al., 1997). Moreover, Ced-4 can compete
for interaction of procaspase-8 with the predicted endoge-
nous molecule(s) in mammalian cells that bridges this Bcl-2
protein with procaspase-8. Ced-4, like the cytosolic tail of
p28, may contain a weak death effector homologous do-
main (Bauer et al., 1997). These findings all conform with
the predicted function of the putative p28 apoptotic signal-
ing complex described here. Moreover, they raise the pos-
sibility that the mammalian homologue of Ced-4, if one
exists, may be a constituent of this complex.Ng et al. Bcl-2 and pro FLICE-associated Bap31 337
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